Identification Of Clonal Skin Myeloid Cells By Next-Generation Sequencing In Myelodysplasia Cutis (Vol 184, Pg 367, 2021)
BRITISH JOURNAL OF DERMATOLOGY(2021)
摘要
Myelodysplastic syndromes (MDS) are malignant hematopoietic stem cell disorders characterized by dysplastic and ineffective blood cell production leading to blood cytopenias, and a risk of transformation to acute myeloid leukemia (AML). Skin lesions in patients with MDS include Sweet syndrome (SS), leucocytoclastic vasculitis, leukemia cutis and histiocytoid SS (H-SS), among others,.1,2 H-SS is a histological variant of SS differing from classical neutrophilic SS by a dermal infiltrate mostly made of immature cells of the myeloid lineage, that has been associated with myeloid malignancies.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要